Conclusions: A great discrepancy in APCA prevalence detected by different methods in this cohort was apparent. Thus, the results on APCA prevalence in healthy individuals are likely method-dependent.
Autoimmune gastritis (AG) is one of the commonest organ-specific autoimmune diseases. It may be present as isolated disease or in association with other autoimmune diseases, notably autoimmune thyroid disease, 1,2 type 3 multiple autoimmune syndrome, 3, 4 or type 1 diabetes mellitus. [5] [6] [7] The typical histologic picture of AG is a body gastritis at variance from antral gastritis due to Helicobacter pylori infection, which evolves towards mucosal atrophy and intestinal metaplasia. [8] [9] [10] [11] The importance of AG as a cause of atrophy has probably been underestimated due to overwhelming attention to H pylori infection. It is conceivable that, with the expected decrease of H pylori infection prevalence in developed countries, more attention will be focused on AG-related gastric atrophy. 12 Whatever the real role played in the pathogenic mechanism, AG and H pylori-induced gastritis may associate and synergize in causing gastric mucosa atrophy/intestinal metaplasia 13 and increasing the risk of gastric malignancies. [14] [15] [16] [17] [18] [19] [20] Although AG is more often considered as a risk factor for malignancies, the most frequent clinical manifestation is anemia due to vitamin B 12 and/or iron deficiency. [21] [22] [23] [24] The prevalence of AG has been estimated to be about 2% in the general population. However, such estimated data are largely circumstantial considering the different histologic and serologic approaches that have been employed to diagnose AG.
Since their discovery, serum autoantibodies directed against gastric parietal cells (anti-parietal cell antibodies, APCA) have been associated with AG, and have become an important tool for AG diagnosis. 12, 19, 21 APCA positivity has been reported in 80% to 90% of patients with AG 26, 27 and in subjects free from clinical gastric disease, but prone to develop AG, such as those suffering from other autoimmune diseases, especially autoimmune thyroid diseases. 1, 28 A recent survey in a large cohort of unselected people reported a prevalence as high as 19%. 29 However, the age range of this study group was relatively high (50-74 years), and more than 50% of patients were positive for H pylori infection.
Initially, APCA were detected by means of indirect immunofluorescence (IIF); later, the finding that the gastric H + /K + ATPase proton pump is the main autoantigen recognized by APCA has led to the development of specific immunometric methods. 21, 28, [30] [31] [32] [33] [34] [35] However, in the different series of published data concerning either patients suffering from, or suspected of having, specific diseases, or apparently healthy individuals, different assay methods have been used. 28, 29, [36] [37] [38] [39] [40] Enzyme-linked immunosorbent assay (ELISA) is believed to be consistently more sensitive than IIF in detecting APCA 35 ; however, only few data comparing different APCA assays are available. The study by Toh et al, 35 on a group of subjects undergoing routine diagnostic workup, showed a higher sensitivity for ELISA compared to IIF without significant loss of specificity (as also shown by control experiments using western blot with both α and β chains of H + /K + ATPase proton pump autoantigen). These authors used primate tissue as the autoantigen source for IIF and purified porcine autoantigen for ELISA.
Thus, data from the literature on the prevalence of APCA in the healthy population are lacking and their possible predictive role in the development of AG is still to be ascertained. In this study we aimed to evaluate the prevalence of APCA in a large group of healthy individuals, randomly selected from a cohort of regular blood donors, using both ELISA, specific for porcine gastric H + /K + ATPase, and IIF on primate and rodent substrates. These subjects may be considered at low risk for AG, according to their sex and age distribution, as well as normal hemoglobin levels.
Materials and Methods

Study Subjects
This cross-sectional study involved 515 individuals (393 males, 122 females; mean age, 45.9 and 43.7 years, respectively; range, 22-65 years) randomly selected from a large cohort of healthy regular blood donors living in Bergamo, Italy. The male/female ratio and age range of the random sample is closely similar to that of the total cohort (about 19,000 individuals). They were originally recruited from 2010 to 2013 through the Italian Association of Voluntary Blood Donors for a study on the prevalence of celiac disease in the local population of blood donors. All subjects with a regular donation activity were included in the original study. Such a population may reasonably be considered at low risk for AG, being mainly represented by male subjects without anemia. The 515 donors included in this study were all negative for celiac disease-associated antibodies.
For each subject a blood sample was collected; the serum obtained after centrifugation was subdivided in separate aliquots and stored at -20°C until APCA determinations were performed.
The study design and the specific protocol were approved by the local ethical committee and follows the World Medical Association Declaration of Helsinki; each volunteer provided written informed consent.
IIF APCA Detection
APCA were detected by IIF on tissue sections of rat stomach (Inova Diagnostics, San Diego, CA) and on primate (monkey) stomach (Euroimmun, Lübeck, Germany). For rodent tissue, serum samples were tested at an initial dilution of 1:40 (cutoff recommended by the manufacturer) and, if positive, at increasing serial dilutions up to 1:640. For primate tissue, serum samples were tested at the initial dilution of 1:10 (manufacturer's cutoff) and then, if positive, at semilog progressive dilutions (1:32, 1:100, 1:320, 1:1,000). Bound antibodies were detected by incubation with a fluorescein isothiocyanate-labeled anti-IgG conjugate. Automated sample processors were used as for routine diagnostics, and the procedure was validated by routine external and internal quality controls. The processed samples were read using a light emitting diode (LED)-light fluorescence microscope by two expert immunopathologists.
ELISA APCA (Gastric H + /K + ATPase Autoantibodies) Detection
ELISA method employing gastric H + /K + ATPase purified from porcine gastric mucosa by affinity chromatography as autoantigen was used to detect APCA IgG antibodies. A rabbit peroxidase-conjugated anti-human IgG antiserum was used as a secondary antibody, according to the protocol recommended by the manufacturer (Euroimmun). Samples were assayed using an automated ELISA processing station (Euroimmun). The manufacturer's cutoff (20 relative units [RU]/mL) was considered to define positive results. Between-assay coefficients of variation at the middle range of the standard curve did not exceed 4.5%.
Immunoblot for Porcine Gastric H + /K + ATPase
Immunoblot was performed as previously described. 35 Briefly, gastric H + /K + ATPase purified from porcine gastric mucosa (0.1 μg protein per test strip) was separated on the basis of molecular mass by discontinuous polyacrylamide gel electrophoresis and transferred onto a nitrocellulose membrane. Serum antibodies against α-and β-chains of gastric H + /K + ATPase were detected using a goat anti-human IgG antibody conjugated with alkaline phosphatase and 5-bromo-4-chloro-3-indoryl phosphate/nitroblue tetrazolium as chromogenic substrate. The results are expressed on a qualitative basis (positive or negative staining).
Statistical Analysis
Cohen K coefficient, Spearman correlation, and χ 2 were applied where appropriate for statistical analysis by means of an SPSS statistic package (SPSS, Chicago, IL). P values less than .05 were considered to be significant.
Results
Overall, 53 of 515 (10.3%) subjects were found positive by at least one of the analytical methods used in this study. Sixteen sera (3.1%) were positive by IIF on sections of rat stomach at a titer ranging from 1:40 to 1:640
Twenty Among the 53 positive subjects, 18 were positive only by ELISA, 10 only by IIF on rodent tissue, and one only by IIF on primate tissue; 18 were positive by ELISA and by IIF on primate tissue and one by ELISA and IIF on rodent tissue. Two sera were positive by both the IIF methods and three sera were triple positive. The distribution of positive sera by each method is shown in the Venn diagram of ❚Figure 4❚ and in ❚Figure 5❚.
Thus, a great discrepancy was apparent between ELISA and IIF rat tissue findings and between the two IIF methods. This is also shown by Cohen κ values for comparison between methods, as depicted in ❚Table 1❚.
Considering only positive sera, no correlation was observed between IIF titers and ELISA units (P = .58, primate IIF vs ELISA; P = .65, rat IIF vs ELISA; P = .66 primate IIF vs rat IIF).
When samples were tested for reactivity against gastric H + /K + ATPase by immunoblot, all 18 sera positive by ELISA and negative by IIF reacted with both α and β subunits (specific 95 kDa and 60-90 kDa bands). Of the 21 sera that were ELISA and IIF-primate double positive, 18 reacted with both α and β subunits, while three samples showed reactivity only with the α subunit ❚Table 2❚. Only three out of the 10 sera exhibiting IIF positivity on rat, but neither on primate section nor by ELISA, stained the β chain of H + /K + ATPase; in the other seven the immunoblot result was negative. Among the two sera that were ELISA negative but IIF positive both on rat and on primate substrates, one was positive for both chains in immunoblot whereas the other was negative. Taken together, APCA positivity was confirmed by immunoblot in all 40 of 40 (100%) samples that were positive by ELISA, in 23 of 24 (95.8%) of the samples that were positive by IIF on primate tissue, and only in eight of 16 (50%) of the samples that tested positive on rat tissue. However, because four out of the eight rat tissue-positive sera were positive also by ELISA, and another one was reactive also on primate tissue, only three of eight of the rat tissue-positive findings were confirmed by immunoblot.
It should be noted that the eight rat tissue-positive sera that failed to stain the α or the β chain of the H 
Discussion
There is increasing evidence that the prevalence of AG is far from negligible and that this may have some impact on public health, both as a cause of anemia due to vitamin B 12 or iron deficiency and as a predisposing factor for gastric malignancies (although the epidemiologic weight of the latter has still to be exactly defined). 11, 14, [41] [42] [43] In addition, comparative evaluations with different methods are lacking in the literature. As an example, a recent extensive meta-analysis of studies on APCA prevalence in subjects with type 1 diabetes mellitus did not take into account the analytical methods used for APCA tests. 44 Therefore, in the present study we aimed to (1) evaluate the prevalence of APCA positivity in a large series of apparently healthy individuals, randomly selected from a cohort of regular blood donors (that can be regarded as at low risk of having AG) and (2) between ELISA and IIF using both rodent tissue section (still widely used in clinical routine) and primate stomach sections, in the specific setting of screening/case finding procedures.
On the first point, in our cohort of healthy subjects, we found an APCA prevalence of 7.8% by ELISA. Such a high prevalence is surprising considering the composition of our cohort, comprising subjects who were young nonanemic blood donors, predominantly male, and at low risk of AG. As expected, autoantibody levels were low in the majority of cases, with some exceptions. It has to be noted that in a population defined as "normal, healthy" the expected levels of APCA, when present, are in most instances low, and the impact of different sensitivity/specificity of the methods is likely higher. 35 In addition, we did not observe any significant correlation of autoantibody positivity with female sex, nor an increase of antibody prevalence with age (as observed for example in the series of Toh et al, 35 which included individuals undergoing APCA determination for diagnostic purposes). Unfortunately, the limited amount of serum available did not allow the evaluation of other related/ relevant immunologic variables on the same sample, such as H pylori antibodies or thyroid peroxidase antibodies. However, these blood donors are currently followed up for possible elevation of circulating gastrin levels, decreased hemoglobin, or RBC abnormalities. This will answer the question as to what extent the presence of APCA (especially at low concentrations) in such a lowrisk population may represent a significant risk factor for disease development.
As far as the second point is concerned, our data confirm a higher analytical sensitivity of ELISA compared to IIF. Data obtained by a third structurally different method, namely, immunoblot using both α and β chains of the gastric H + /K + ATPase autoantigen, support the concept of a good specificity of ELISA, in agreement with the only published study comparing IIF and ELISA 35 ; indeed, sera showing even low autoantibody concentrations by ELISA gave a positive signal in immunoblot. Note that in such sera both α and β H + /K + ATPase chains staining was observed. This fact, in spite of the nonhuman source of the antigen, may be regarded as a fair proof of assay specificity, as remarked previously. 35 In only a minority of sera, positive findings by IIF and negative by ELISA were confirmed by immunoblot, in most instances, for one chain only of the autoantigen. In the other cases, isolated low-titer IIF positivity (as a rule, on rat tissue sections) was likely a false positive. Thus, ELISA positivities are probably specific even in the absence of positivity in IIF.
The overall qualitative agreement between ELISA and IIF on primate tissue was fair, as shown by Cohen κ value, though the correlation between IIF titers and quantitative units on ELISA did not reach statistical significance. Conversely, the agreement of ELISA with IIF on rat substrates was poor, as well as the agreement between IIF results using different substrates. At least in these conditions (population at very low risk), the value of low-titer positivity obtained on rat substrate only is probably questionable. In addition, the finding that all three sera that were positive by IIF only on rat tissue were reactive only with the β chain of H + /K + ATPase, while 39 of 40 of the ELISA positive sera and 23 of 24 of the primate IIF positive sera were reactive with the α chain (alone or together with the β chain), raises the question of whether antibodies directed exclusively to the β chain may be clinically less specific for AG than antibodies against the α chain. This intriguing experimental observation has, to our knowledge, never been previously reported and deserves further investigation. This point will be addressed during follow-up.
The different analytical performance of APCA assays we observed in our study group of healthy individuals, where a low frequency of positivity and low antibody levels were expected, do not necessarily imply similar differences in diagnostic accuracy in the workup of AG patients. In fact, preliminary results obtained in a pilot sample of 28 patients with biopsy-proven AG failed to show major discrepancies among different methods. In detail, all 28 patients showed high-titer positivity for APCA IIF on both monkey and rat substrates (from 1:100 up to 1:1,000), and positive APCA levels by quantitative ELISA (from 29.2 up to 296.9 RU/mL). Thus, in the presence of high APCA concentrations, the analytical performances of APCA IIF with monkey or rat substrates may be quite similar.
In conclusion, the results of studies on APCA prevalence deriving from survey/screening procedures on 
